NEW YORK, NY--(Marketwired - Jan 9, 2014) - There aren't too many biotechnology companies in the marijuana space, but there's one that aims to be the leader among those in the industry. Nuvilex, Inc. (
Late last year, Dr. Mark Rabe, a well-known figure in the medical marijuana industry, was named as Chairman of the Scientific Advisory Board (SAB) for Medical Marijuana Sciences (MMS). In a recent statement by the company, Dr. Rabe issued a Charter with both the mission and a list of goals and objectives for the SAB.
Dr. Rabe vowed to recruit members to the SAB with stellar credentials, and this week the first of those recruits was named. Richard M. Hyslop, Ph.D. agreed to join Dr. Rabe on the SAB of MMS. Dr. Hyslop is a Professor of Chemistry and Biochemistry at the University of Northern Colorado.
With his expertise in anti-cancer drug design, the metabolism of anti-cancer drugs and studies of enzymes and enzyme-catalyzed reactions in biological tissues, Dr. Rabe expects that Dr. Hyslop will be an asset to the future success of MMS. Another advantage Dr. Hyslop brings to the table is that he's located in Colorado, a state that has legalized medical marijuana.
As the recruiting continues at MMS, Dr. Rabe is sure to only strengthen the company with a diverse team that can meet the goals he's set for Medical Marijuana Sciences including, developing treatments, which employ constituents of Cannabis together with the Cell-in-a-Box™ cellulose-based live-cell encapsulation technology, for some of the deadliest forms of cancer.
Nuvilex and MMS COO Dr. Gerald Crabtree said, "We believe that when the roster of SAB members is filled, the SAB will play a major role in fulfilling the goals and objectives of Medical Marijuana Sciences."
About Stock Market Media Group
SMMG is a full service IR firm specializing in Research and Content Development. It offers a platform for corporate stories to unfold through the media with Reports, Interviews and Articles. For more information and to read disclaimers and disclosures: www.stockmarketmediagroup.com.